According to the Mulitple Myeloma Research Foundation, immunotherapy is a collection of approaches that trains and directs the body’s natural immune system to attack cancer cells. In 2020, MMRF will focus on several specific types of immunotherapy that show promise for myeloma, including chimeric antigen receptor T-cell (CAR-T) therapy, vaccines, and monoclonal antibodies.
The D Jones Family Charitable Foundation continues its support of MMRF in its fight to cure Myeloma with a grant specifically for the development of the CAR-T therapy and clinical trials. To read more about this initiative, please visit the Multiple Myeloma Research Foundation website by clicking here.